BridgeMD
New treatment option for Parkinson's Disease and Parkinsonism
Official title Sensing in Sleep Deep Brain Stimulation
ClinicalTrials.gov ID: NCT07636720
What this study is testing
- What it's testing
- Participants in this study have Parkinson's Disease and already have a device, called the Percept RC Deep Brain Stimulation device implanted. People with Parkinson's disease often have issues related to sleep such as bad quality of sleep, waking up often and sleep apnea (breathing stops and starts during sleep).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 80
You may be able to join if
- Ability of subject to understand and the willingness to sign a written informed consent document.
- Males and females; Age 40-80
- people with the diagnosis of idiopathic PD consistent with the United Kingdom Parkinson Disease society brain bank criteria, or documented diagnosis...
- Willingness to adhere to the PSG regimen and turn DBS off for one night.
- A score of ≥23 on the Montreal Cognitive Assessment (MoCA)
You likely can't join if
- History of severe cardiovascular disease, untreated obstructive sleep apnea (OSA).
- History of other neurological disorders affecting the central nervous system such as stroke, multiple sclerosis, tumors, amyotrophic lateral...
- History of Dementia.
- Report dopaminergic medication changes in the past month.
See the full eligibility criteria
- Ability of subject to understand and the willingness to sign a written informed consent document.
- Males and females; Age 40-80
- people with the diagnosis of idiopathic PD consistent with the United Kingdom Parkinson Disease society brain bank criteria, or documented diagnosis of Parkinson Disease who have a Deep Brain Implant, Percept RC device...
- Willingness to adhere to the PSG regimen and turn DBS off for one night.
- A score of ≥23 on the Montreal Cognitive Assessment (MoCA)
- Be willing to stop any sleep hypnotics such as benzodiazepines and Ambien, with a 3 day washout period.
- History of severe cardiovascular disease, untreated obstructive sleep apnea (OSA).
- History of other neurological disorders affecting the central nervous system such as stroke, multiple sclerosis, tumors, amyotrophic lateral sclerosis or muscle disease such as muscular dystrophy, myopathy.
- History of Dementia.
- Report dopaminergic medication changes in the past month.
The study team makes the final eligibility decision.
Where it's taking place
- San Antonio, Texas, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include San Antonio, Texas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.